✦ LIBER ✦

Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open-label, dose-escalation study

✍ Scribed by Ariel C. Bulua; Douglas B. Mogul; Ivona Aksentijevich; Harjot Singh; David Y. He; Larry R. Muenz; Michael M. Ward; Cheryl H. Yarboro; Daniel L. Kastner; Richard M. Siegel; Keith M. Hull

Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 269 KB
Volume: 64
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.33416

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistent efficacy of anakinra in patie

Persistent efficacy of anakinra in patients with tumor necrosis factor receptor–associated periodic syndrome

✍ M. Gattorno; M. A. Pelagatti; A. Meini; L. Obici; R. Barcellona; S. Federici; A. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Proinflammatory action of the antiinflam

Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor–associated periodic syndrome

✍ Belinda Nedjai; Graham A. Hitman; Niamh Quillinan; Robert J. Coughlan; Leigh Chu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Role of interleukin-6 in a patient with

Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab

✍ Prashantha M. Vaitla; Paul M. Radford; Patrick J. Tighe; Richard J. Powell; Eliz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views